Prevymis 480 mg

Prevymis 480 mg is an antiviral medication used to prevent cytomegalovirus (CMV) reactivation. This oral tablet, containing letermovir, is commonly prescribed for patients undergoing stem cell transplants.

Prevymis 480 mg is primarily used to prevent CMV reactivation in adults who have received a stem cell transplant. CMV is a virus that can cause serious infections in people with weakened immune systems. This medication works by inhibiting the virus's ability to replicate, thereby reducing the risk of CMV-related complications. Patients often wonder, 'What is Prevymis used for?' and the answer lies in its role in managing CMV in transplant recipients.

Common effects of Prevymis 480 mg may include nausea, fatigue, and diarrhea. Some users might experience headaches or abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Prevymis should be handled with care, especially by individuals with known allergies to letermovir or any of its components. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Prevymis may interact with certain medications, particularly those metabolized by the liver enzyme CYP3A. This includes drugs like cyclosporine and other antiviral medications. Consuming alcohol while taking Prevymis is not recommended, as it may increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.